Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Gastric Acid Suppression on Probiotic Colonization
NCT03327051Phase 4Completed
- Sponsor
- Stanford University
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Stanford University. Started Mar 2018; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03327051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327051.